These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 17510391
1. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C. Cancer Res; 2007 May 15; 67(10):4657-64. PubMed ID: 17510391 [Abstract] [Full Text] [Related]
2. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C. J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832 [Abstract] [Full Text] [Related]
3. Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma. Bennett KL, Romigh T, Arab K, Teresi RE, Tada Y, Eng C, Plass C. Int J Cancer; 2009 Mar 15; 124(6):1285-92. PubMed ID: 19089912 [Abstract] [Full Text] [Related]
4. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. Cancer Res; 2002 Jan 15; 62(2):528-34. PubMed ID: 11809705 [Abstract] [Full Text] [Related]
5. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation. Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC. Cancer Res; 2005 Feb 01; 65(3):861-7. PubMed ID: 15705884 [Abstract] [Full Text] [Related]
6. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Takai N, Kawamata N, Walsh CS, Gery S, Desmond JC, Whittaker S, Said JW, Popoviciu LM, Jones PA, Miyakawa I, Koeffler HP. Mol Cancer Res; 2005 May 01; 3(5):261-9. PubMed ID: 15886297 [Abstract] [Full Text] [Related]
7. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Carvalho AL, Chuang A, Jiang WW, Lee J, Begum S, Poeta L, Zhao M, Jerónimo C, Henrique R, Nayak CS, Park HL, Brait MR, Liu C, Zhou S, Koch W, Fazio VM, Ratovitski E, Trink B, Westra W, Sidransky D, Moon CS, Califano JA. Cancer Res; 2006 Oct 01; 66(19):9401-7. PubMed ID: 17018594 [Abstract] [Full Text] [Related]
8. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma. Brieger J, Pongsapich W, Mann SA, Hedrich J, Fruth K, Pogozelski B, Mann WJ. Oral Oncol; 2010 Sep 01; 46(9):678-83. PubMed ID: 20729134 [Abstract] [Full Text] [Related]
9. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms. Zolk O, Schnepf R, Muschler M, Fromm MF, Wendler O, Traxdorf M, Iro H, Zenk J. Am J Pathol; 2013 Jan 01; 182(1):234-43. PubMed ID: 23137910 [Abstract] [Full Text] [Related]
18. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Zeng C, Wang R, Li D, Lin XJ, Wei QK, Yuan Y, Wang Q, Chen W, Zhuang SM. Hepatology; 2010 Nov 01; 52(5):1702-12. PubMed ID: 21038412 [Abstract] [Full Text] [Related]
19. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines. Lee DW, Park SW, Park SY, Heo DS, Kim KH, Sung MW. Head Neck; 2004 Aug 01; 26(8):706-15. PubMed ID: 15287038 [Abstract] [Full Text] [Related]